ACURX PHARMACEUTICALS, INC. (ACXP)
Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Leiden Early Drug Discovery & Development (LED3) Scientific Conference
📈 **POSITIVE** • High confidence analysis (91%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business